Skip to main content
Caplight Logo









Karavela

Karavela

Private
ParisHealthcare & Life Scienceshttps://karavela.ai/en

Last Round

Pre Seed

Aug 22, 2025

Total Funding Raised

$2.32M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Karavela is a healthcare and digital health company that develops brain foundation models using magnetic resonance imaging data to enhance clinical trials and neurological diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Imaging, Drug Discovery, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Foundation

Keywords

foundation modelbrain foundation modelfMRIfunctional magnetic resonance imagingneurological drug developmentclinical trial optimizationpatient stratificationbiomarker identificationbrain decodingfrontier AI labmedical AIneurotechdeep learningtransformer modelsclinical research organizationCRObiotech AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Karavela Comparables

Compare Karavela with similar companies based on industry and business-model similarity.

Karavela comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ceretype Neuromedicine, Inc.
83%
Qynapse
69%
IXICO plc
67%

Karavela Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedAug 22, 2025

Key People

Founding team and executive leadership

Alexis Thual

Cofounder & CEO

Founding Team

Karavela Investors

Notable investors and investment history

Karavela investors
InvestorRounds
DaphniPre Seed
First Momentum VenturesPre Seed
HCVCPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 7, 2026

    Open roles increased to 9, 4.5x the trailing average.

  • May 27, 2026

    Grew 50% QoQ, from 6 to 9 employees.

Karavela Filings

Explore SEC and related filing metadata, where available.

Karavela filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Karavela's valuation, stock price, and market status.

Is Karavela a public or private company?

Karavela is a private company.

What is the current stock price of Karavela?

Karavela is a private company with no public stock price. Caplight tracks Karavela's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Karavela worth (valuation)?

Valuation information for Karavela is not publicly available.

Can I buy Karavela stock?

Karavela shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Karavela's last funding round?

Karavela's most recent funding round was Pre Seed on August 22, 2025.

Who are the main investors in Karavela?

Key investors in Karavela include Daphni, First Momentum Ventures, HCVC.

Will Karavela IPO soon?

No public IPO plans have been announced for Karavela.

How can I track Karavela secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Karavela's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Employee Range9
Year Founded2025
Last FundingAug 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?